RxDoctor Payments DataLook up a doctor →

Thomas von Unrug, MD

Internal Medicine · Lexington, KYNPI 1295779957

Payments from drug & device makers

$22,059in general payments, 2019–2025

Across 1,074 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • AbbVie$3K
  • AstraZeneca$2K
  • Bayer$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Novo Nordisk$1K
  • plus $9K from 46 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)138$3,271
AbbVie(2 entities)248$2,760
AstraZeneca82$2,495
Bayer77$2,102
Teva Pharmaceuticals USA, Inc.53$1,143
Novo Nordisk31$1,042
Johnson & Johnson38$1,014
Pfizer46$876
Boehringer Ingelheim28$799
Novartis43$795
Astellas Pharma US Inc29$789
Lilly USA, LLC48$698
Redhill Biopharma Inc.77$587
Amarin Pharma, Inc.12$481
Esperion Therapeutics, Inc.2$231
GSK10$197
UCB, Inc.4$184
Biohaven Pharmaceutical Holding Company Ltd.6$181
Idorsia Pharmaceuticals US Inc4$180
Pulmonx Corporation1$175
Takeda Pharmaceuticals U.S.A., Inc.10$161
Verona Pharma, Inc.2$143
Phathom Pharmaceuticals, Inc.2$141
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$140
Vifor Pharma, Inc.6$137
Merck9$135
Eisai Inc.7$130
Antares Pharma, Inc.6$121
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$119
Sunovion Pharmaceuticals Inc.6$110
Abbott5$92
Sanofi-aventis U.S. LLC5$73
Scpharmaceuticals Inc.1$57
Kowa Pharmaceuticals America, Inc.2$47
Radius Health, Inc.3$45
E.r. Squibb & Sons, L.L.C.3$44
Ultragenyx Pharmaceutical Inc.2$41
Xeris Pharmaceuticals, Inc.2$40
Dexcom, Inc.2$32
Abiomed1$31
Biohaven Pharmaceuticals, Inc.2$30
Lundbeck LLC1$22
Endo Pharmaceuticals Inc.1$21
Otsuka America Pharmaceutical, Inc.1$19
Organogenesis Inc.1$19
Arbor Pharmaceuticals, Inc.1$19
Glenmark Therapeutics Inc.1$17
Bioventus LLC1$16
Paratek Pharmaceuticals, Inc.1$15
MDD US Operations, LLC1$14
Acadia Pharmaceuticals Inc1$14
Nabriva Therapeutics, PLC1$12

How this compares

$22,059 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky →

Medicare billing

Part B allowed, 2024
$287,316
Medicare patients
192
Services billed
3,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Lexington

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →